Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Comparison of 90° and 120° Arm Positions in Costoclavicular Block (COSTO-RCT)

6 giugno 2026 aggiornato da: ALGAN TURGUT ÇARSANCAKLI, Ankara Etlik City Hospital

Effect of Arm Abduction Degree ( 90° vs. 120° ) on Block Onset Time and Block Success in Costoclavicular Brachial Plexus Block in Patients Undergoing Hand, Wrist and Forearm Surgery: A Prospective Randomized Controlled Trial

The costoclavicular approach of the infraclavicular brachial plexus block is widely used for upper extremity surgeries due to its reliable anatomy and high success rates. Patient positioning, particularly the degree of arm abduction, may influence the spread of local anesthetic and the characteristics of the block. However, the optimal arm abduction angle during this procedure remains unclear.

This prospective randomized controlled trial aims to investigate the effect of two different arm abduction angles (90° and 120°) on block onset time and block success in patients undergoing hand, wrist, and forearm surgery under ultrasound-guided costoclavicular brachial plexus block.

Patients will be randomly assigned to one of two groups according to the degree of arm abduction. The primary outcome is block onset time. Secondary outcomes include block success, sensory and motor block characteristics, perfusion index changes, hemodynamic parameters, readiness for surgery at 15 and 20 minutes, block performance time, need for additional anesthesia, postoperative neurological evaluation at 4 and 24 hours, complications, and patient satisfaction.

The findings of this study are expected to provide evidence on optimal patient positioning to improve the effectiveness and reliability of ultrasound-guided costoclavicular brachial plexus block.

Panoramica dello studio

Descrizione dettagliata

The costoclavicular approach is a recently described infraclavicular technique for brachial plexus block that provides reliable anesthesia for upper extremity surgeries. Due to the compact arrangement of the cords in the costoclavicular space, this technique has gained popularity for its high success rates and consistent anatomy. However, procedural factors such as patient positioning may influence the distribution of local anesthetic and the effectiveness of the block.

Arm abduction is known to alter the anatomical relationships within the infraclavicular region, potentially affecting needle visualization, spread of local anesthetic, and block characteristics. Despite its clinical relevance, there is limited evidence regarding the optimal degree of arm abduction during ultrasound-guided costoclavicular brachial plexus block.

This prospective randomized controlled study aims to compare two different arm abduction angles 90° and 120° in patients undergoing elective hand, wrist, and forearm surgery. After obtaining written informed consent, eligible patients will be randomly assigned into two groups according to the degree of arm abduction.

All procedures will be performed under ultrasound guidance using a standardized technique. The local anesthetic will be administered in the costoclavicular space, and block characteristics will be assessed systematically. The primary outcome is block onset time, defined as the time from completion of local anesthetic injection to the achievement of adequate sensory block for surgery.

Secondary outcomes include block success, sensory and motor block scores, perfusion index measurements, hemodynamic parameters, readiness for surgery at 15 and 20 minutes, block performance time, need for additional anesthesia or conversion to general anesthesia, early complications, postoperative neurological evaluation at 4 and 24 hours, and patient satisfaction assessed using a Likert scale.

The results of this study are expected to provide valuable evidence regarding optimal patient positioning and contribute to improving the clinical effectiveness and reliability of ultrasound-guided costoclavicular brachial plexus block.

Tipo di studio

Interventistico

Iscrizione (Stimato)

106

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

  • Nome: Algan TURGUT ÇARSANCAKLI, M.D.
  • Numero di telefono: +90 532 486 52 69
  • Email: alganturgut@gmail.com

Backup dei contatti dello studio

  • Nome: Reyhan POLAT, Professor
  • Numero di telefono: +90 532 673 43 10
  • Email: reyhanp9@gmail.com

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  • Patients aged between 18 and 80 years.
  • Patients scheduled for elective upper extremity surgery (hand, wrist, forearm).
  • Patients classified as ASA I-III.
  • Patients who provide informed consent after being informed about the study.

Exclusion Criteria:

  • History of previous surgery, scar tissue, tumor, or trauma that may alter brachial plexus anatomy.
  • Presence of infection, hematoma, severe edema, burn, or open wound at the block application site.
  • Known allergy to local anesthetics or other medications used in the study.
  • Coagulopathy, use of anticoagulants, or platelet count < 100,000/mm³.
  • History of peripheral neuropathy, neurological deficit, cervical radiculopathy, or CRPS.
  • Pregnancy or breastfeeding.
  • Patients with BMI < 18 kg/m².
  • Patients with BMI > 35 kg/m².
  • Severe cardiac, pulmonary, renal, or hepatic failure.
  • Mental retardation, communication difficulties, or lack of cooperation.
  • Deformity, amputation, or large mass in the surgical extremity that may interfere with sensorimotor assessment.
  • Preoperative significant sensory loss, motor weakness, or signs of neurological disease.
  • Severe anemia (Hb < 9 g/dL) or polycythemia (Hb > 18 g/dL).
  • Psychiatric disorders, substance abuse, or any condition that may interfere with study compliance.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Selezione
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: 90° Arm Abduction
Patients receive ultrasound-guided costoclavicular brachial plexus block with the arm positioned at 90° abduction.
Ultra-sound Guided costoclavicular brachial plexus block performed for upper extremity surgery using a standard local anesthetic technique
Sperimentale: 120° Arm Abduction
Patients receive ultrasound-guided costoclavicular brachial plexus block with the arm positioned at 120° abduction.
Ultra-sound Guided costoclavicular brachial plexus block performed for upper extremity surgery using a standard local anesthetic technique

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Block Onset Time
Lasso di tempo: Up to 30 minutes after block performance
Time from completion of local anesthetic injection to achievement of adequate sensory block sufficient for surgery, assessed by pinprick test.
Up to 30 minutes after block performance

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Block Success
Lasso di tempo: İntraoperative period
Successful completion of surgery without the need for additional anesthesia.
İntraoperative period
Sensory Block Score
Lasso di tempo: Baseline and at 5-minute intervals up to 20 minutes after block performance.
Sensory block was assessed using a 3-point pinprick scale ( 0= normal sensation, 1= loss of pinprick sensation, 2= complete sensory block).
Baseline and at 5-minute intervals up to 20 minutes after block performance.
Motor Block Score
Lasso di tempo: Baseline and at 5-minute intervals up to 30 minutes after block performance.
Motor block was assessed using a 3-point motor scale (0= normal motor function, 1= reduced motor strength, 20 complete motor block).
Baseline and at 5-minute intervals up to 30 minutes after block performance.
Perfusion Index
Lasso di tempo: Baseline and at 5,10,15 and 20 minutes after block performance.
Perfusion index values measured using a Masimo pulse oximeter probe placed on the blocked upper extremity.
Baseline and at 5,10,15 and 20 minutes after block performance.
Readiness for Surgery
Lasso di tempo: 15 minutes after block
Proportion of patients ready for surgery at 15 and 20 minutes.
15 minutes after block
Readiness for Surgery
Lasso di tempo: 20 minutes after block
Proportion of patients ready for surgery at 15 and 20 minutes
20 minutes after block
Block Performance Time
Lasso di tempo: During procedure ( min )
Time required to perform the block.
During procedure ( min )
Need for Additional Anesthesia
Lasso di tempo: Intraoperative period
Requirement for supplemental anesthesia or conversion to general anesthesia.
Intraoperative period
Complications
Lasso di tempo: Up to 24 hours
Early complications related to block
Up to 24 hours
Postoperative Sensory and Motor Function Assessment
Lasso di tempo: 4 hours after surgery
Postoperative neurological evaluation including sensory and motor function examination of the blocked upper extremity to assess for neurological complications.
4 hours after surgery
Postoperative Sensory and Motor Function Assessment
Lasso di tempo: 24 hours after surgery
Postoperative neurological evaluation including sensory and motor function examination of the blocked upper extremity to assess for neurological complications.
24 hours after surgery
Patient Satisfaction
Lasso di tempo: At the end of the surgery and 24 hours postoperatively
Patient satisfaction assessed using a 5-point Likert scale, where 1 indicates very dissatisfied and 5 indicates very satisfied.
At the end of the surgery and 24 hours postoperatively
Hemodynamic Parametres
Lasso di tempo: Baseline and at 5,10,15 and 20minutes after block performance
Heart rate
Baseline and at 5,10,15 and 20minutes after block performance
Systolic Blood Pressure
Lasso di tempo: Baseline and at 5,10,15 and 20 minutes after block performance.
Systolic blood pressure values measured during and after block performance.
Baseline and at 5,10,15 and 20 minutes after block performance.
Diastolic Blood Pressure
Lasso di tempo: Baseline and at 5,10,15 and 20 minutes after block performance.
Diastolic blood pressure values measured during and after block performance.
Baseline and at 5,10,15 and 20 minutes after block performance.
Mean Arterial Pressure
Lasso di tempo: Baseline and at 5,10,15 and 20 minutes after block performance.
Mean arterial pressure values measured during and after block performance.
Baseline and at 5,10,15 and 20 minutes after block performance.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Direttore dello studio: Reyhan Polat, Professor, Ankara Etlik City Hospital

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

15 maggio 2026

Completamento primario (Stimato)

15 luglio 2026

Completamento dello studio (Stimato)

27 agosto 2026

Date di iscrizione allo studio

Primo inviato

7 aprile 2026

Primo inviato che soddisfa i criteri di controllo qualità

8 maggio 2026

Primo Inserito (Effettivo)

14 maggio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

9 giugno 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

6 giugno 2026

Ultimo verificato

1 giugno 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • AEŞH-EK-2026-07

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi